Synthesis and antimicrobial activity of N-[5-(3-pyridyl)-1,3,4-thiadiazol- 2-yl] -N′-aroyl urea

Yaoxue Xuebao

Volumn 42, Issue 1, 2007, Pages 108-110

  Dong, Xing Gao ^a   Yan, Ling ^a   Song, Xin Jian ^a   Du, Yin Xiang ^a  

^a HUBEI UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

1,3,4 thiadiazole; Antibacterial activity; Aroyl urea; Synthesis

Indexed keywords

ANTIFUNGAL AGENT; CARBANILAMIDE DERIVATIVE; THIADIAZOLE DERIVATIVE;

ARTICLE; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; SYNTHESIS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PHENYLUREA COMPOUNDS; THIADIAZOLES;

EID: 33847727015     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zou XJ, Lai LH, Jin GY, et al. Synthesis, fungicidal activity and 3D-QSAR of pyridazinone-substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles [J]. J Agric Food Chem, 2002, 50:3757-3760.
2. Foroumadi A, Soltani F, Moshafi MH, et al. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3, 4-thiadiazole-2-yl) piperazinyl quinolone derivatives [J]. Farmaco, 2003, 58:1023 - 1028.
3. Hu GQ, Xie SQ, Xu QJ, et al. Synthesis and antibacterial activity of 3-(5-substituted phenyl-[1,3,4] oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl- [1,2, 4] triazole-4-yl- amines [J]. Acta Pharm Sin, 2005, 40:337-339.
4. Hu GQ, Xu QJ, Liu B, et al. Synthesis and antibacterial activity of 2-(3-pyridyl)-5-{ [ (5-aryl-1,3,4-oxadiazol-2-yl) methylene] thio { -1,3,4-oxadiazoles [J]. Acta Pharm Sin, 2004, 39:263 -265.
5. Patani GA, LaVoie EJ. Bioisosterism: a rational approach in drug design [J]. Chem Rev, 1996, 96: 3147-3176.
6. Schmitt JD. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors [J]. Curr Med Chem, 2000:749-800.
7. Guandalini L, Dei S, Manetti D, et al. Synthesis and pharmacological evaluation of some (pyridyl) cyclopropylmethyl amines and their methiodides as nicotinic receptor ligands [J]. Farmaco, 2002, 57:487 -496.
8. Pevarello P, Amici R, Traquandi G, et al. 2-Ureidothiazole derivatives process for their preparation and their use as antitumor agents: WO, 0026203 [P]. 2000-05-11.
9. Song XJ, Feng GR, Chen CB, et al. Synthesis and biological activity of N-[5-(pyrid-4-yl)-1,3,4-thiadiazol-2-yl]-N′-arovlureas [J]. Chin J Org Chem, 2005, 25:1587-1590.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A [S]. USA: Wayne PA, 1997.
11. Isodal, Suzuki N, Miwa T, et al. Thiazolo[3,2-a] [1, 2,3] triazolo[4,5-d] pyrimidine and [1,3,4] thiadiazolo [3,2-a] [1,2,3] triazolo[4,5-d] pyrimidine derivatives: US, 4652646 [P]. 1987-03-24.